0001209191-19-031424.txt : 20190520
0001209191-19-031424.hdr.sgml : 20190520
20190520163813
ACCESSION NUMBER: 0001209191-19-031424
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190516
FILED AS OF DATE: 20190520
DATE AS OF CHANGE: 20190520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krueger Nancy
CENTRAL INDEX KEY: 0001640869
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 19839297
MAIL ADDRESS:
STREET 1: C/O ATYR PHARMA, INC.
STREET 2: 3545 JOHN HOPKINS COURT, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-731-8389
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT, STE #250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-16
0
0001339970
aTYR PHARMA INC
LIFE
0001640869
Krueger Nancy
3545 JOHN HOPKINS COURT, SUITE 250
SAN DIEGO
CA
92121
0
1
0
0
General Counsel
Common Stock
2019-05-16
4
M
0
12500
0.00
A
29999
D
Common Stock
2019-05-17
4
S
0
4651
0.4501
D
25348
D
Restricted Stock Units
0.00
2019-05-16
4
M
0
12500
0.00
D
Common Stock
12500
12500
D
Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on May 16, 2018.
Includes 2,500 shares acquired under the Company's 2015 Employee Stock Purchase Plan (ESPP) on May 15, 2019.
Sale made by the Reporting Person in compliance with the provisions of Rule 10b5-1 to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on May 16, 2018.
The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on May 16, 2019.
Nancy D. Krueger
2019-05-20